Matriptase regulates c-Met mediated proliferation and invasion in inflammatory breast cancer.
Ontology highlight
ABSTRACT: The poor prognosis for patients with inflammatory breast cancer (IBC) compared to patients with other types of breast cancers emphasizes the need to better understand the molecular underpinnings of this disease with the goal of developing effective targeted therapeutics. Dysregulation of matriptase expression, an epithelial-specific member of the type II transmembrane serine protease family, has been demonstrated in many different cancer types. To date, no studies have assessed the expression and potential pro-oncogenic role of matriptase in IBC. We examined the functional relationship between matriptase and the HGF/c-MET signaling pathway in the IBC cell lines SUM149 and SUM190, and in IBC patient samples. Matriptase and c-Met proteins are localized on the surface membrane of IBC cells an
SUBMITTER: Zoratti GL
PROVIDER: S-EPMC5295421 | biostudies-literature | 2016 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA